| Name | Dovitinib (TKI-258, CHIR-258) | CAS# | 405169-16-6 | |
|---|---|---|---|---|
| Price | ¥Inquiry/1g | Purity | 98.9% | |
| Stocking Period |
1 Day | Stock | In Stock |
| Detail
Product Information
Dovitinib (TKI258, CHIR258) is a novel multi-target inhibitor for Flt3, c-Kit, FGFR1/3, VEGFR1/2/3, PDGFRα/β with IC50 of 1 nM, 2 nM, 8 nM/9 nM and 10 nM/13 nM/8 nM, 210 nM/27 nM respectively. |
Get all suppliers by the below link:
Dovitinib (TKI-258, CHIR-258) suppliers
| 2024-07-15 |
Dovitinib(TKI-258,CHIR-258)
Price: Inquiry |
| 2021-07-26 |
4-Amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]quinolin-2(1H)-one
Price: $Inquiry |
| 2025-09-17 |
Dovitinib (TKI-258, CHIR-258)
Price: ¥Inquiry |
| 2024-07-13 |
Dovitinib
Price: ¥Inquiry |
| 2023-09-13 |
Dovitinib
Price: ¥Inquiry |
| 2024-03-12 |
Dovitinib (TKI-258, CHIR-258)
Price: ¥Inquiry |
| 2022-05-12 |
Dovitinib
Price: $Inquiry |
| 2024-07-15 |
Dovitinib(TKI-258,CHIR-258)
Price: Inquiry |
| 2023-12-04 |
Dovitinib
Price: ¥Inquiry |
| 2020-12-08 |
Dovitinib (TKI-258, CHIR-258)
Price: ¥890.0 |
Get all price from the following link:
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved


